共 50 条
- [1] The prognostic impact of a negative confirmatory biopsy in men on active surveillance for prostate cancer.[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)Salari, KeyanZlatev, Dimitar V.Kuppermann, DavidPreston, Mark A.Dahl, Douglas M.Efstathiou, Jason A.Blute, Michael L.Zietman, Anthony L.Feldman, Adam S.
- [2] Impact of a negative confirmatory biopsy on risk of disease progression among men on active surveillance for prostate cancer[J]. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (09) : 387.e9 - 387.e16Salari, KeyanKowitz, JasonTwum-Ampofo, JeffreyGusev, AndrewO'Shea, AileenAnderson, Mark A.Harisinghani, MukeshKuppermann, DavidDahl, Douglas M.Efstathiou, Jason A.Lee, Richard J.Blute, Michael L.Zietman, Anthony L.Feldman, Adam S.
- [3] Prognostic Significance of a Negative Confirmatory Biopsy on Reclassification Among Men on Active Surveillance[J]. UROLOGY, 2017, 107 : 184 - 189Ganesan, VishnuDai, CharlesNyame, Yaw A.Greene, Daniel J.Almassi, NimaHettel, DanielZabell, JosephArora, HansHaywood, SamuelCrane, AliceReichard, ChadZampini, AnnaElshafei, AhmedStein, Robert J.Fareed, KhaledJones, J. StephenGong, MichaelStephenson, Andrew J.Klein, Eric A.Berglund, Ryan K.
- [4] THE PROGNOSTIC SIGNIFICANCE OF A NEGATIVE CONFIRMATORY PROSTATE BIOPSY ON PROGRESSION FOR PATIENTS ON ACTIVE SURVEILLANCE[J]. JOURNAL OF UROLOGY, 2016, 195 (04): : E155 - E155Ganesan, VishnuDai, CharlesNyame, YawGreene, DanielAlmassi, NimaZabell, JosephArora, HansHaywood, SamCrane, AliceReichard, ChadHettel, DanielZampini, AnnaEl-Shafei, AhmedStein, RobertFareed, KhaledGong, MichaelJones, J. StephenStephenson, AndrewKlein, Eric
- [5] Confirmatory biopsy for the assessment of prostate cancer in men considering active surveillance: reference centre experience[J]. ECANCERMEDICALSCIENCE, 2016, 10Bosco, CeciliaCozzi, GabrieleKinsella, JanetteBianchi, RobertoAcher, PeterChallacombe, BenjaminPopert, RickBrown, ChristianGeorge, GincyVan Hemelrijck, MiekeCahill, Declan
- [6] Age is Associated with Upgrading at Confirmatory Biopsy among Men with Prostate Cancer Treated with Active Surveillance[J]. JOURNAL OF UROLOGY, 2015, 194 (06): : 1607 - 1611Anderson, Christopher B.Sternberg, Itay A.Karen-Paz, GalKim, Philip H.Sjoberg, DanielVargas, Hebert AlbertoTouijer, KarimEastham, James A.Ehdaie, Behfar
- [7] Implications of a Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Along with PTEN/ERG as a Predictor of Pathologic Progression[J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 597 - 597Prasad, AnilLin, KirkPrasad, AshishBartlett, ZaneBelkoff, KennethPage, JayLevine, MichaelShah, Rajal
- [8] Implications of a Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Along with PTEN/ERG as a Predictor of Pathologic Progression[J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 597 - 597Prasad, AnilLin, KirkPrasad, AshishBartlett, ZaneBelkoff, KennethPage, JayLevine, MichaelShah, Rajal
- [9] A Negative Confirmatory Biopsy Among Men on Active Surveillance for Prostate Cancer Does Not Protect Them from Histologic Grade Progression[J]. EUROPEAN UROLOGY, 2014, 66 (03) : 406 - 413Wong, Lih-MingAlibhai, Shabbir M. H.Trottier, GregTimilshina, NarhariVan der Kwast, TheodorusZlotta, AlexandreLawrentschuk, NathanKulkarni, GirishHamilton, RobertFerrara, SarahMargel, DavidTrachtenberg, JohnJewett, Michael A.Toi, AntsEvans, AndrewFleshner, Neil E.Finelli, Antonio
- [10] TIMING OF THE CONFIRMATORY BIOPSY IN PROSTATE CANCER ACTIVE SURVEILLANCE: ANALYSIS OF THE CANARY PROSTATE CANCER ACTIVE SURVEILLANCE STUDY (PASS)[J]. JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755Macleod, Liam C.Ellis, William J.Newcomb, Lisa F.Zheng, YingyeBrooks, James D.Carroll, Peter R.Gleave, Martin E.Lance, Raymond S.Nelson, Peter S.Thompson, Ian M.Wagner, Andrew A.Wei, John T.Yang, Hui-YuLin, Daniel W.